⚠ The Same Pathway Governs Field Actions and RecallsModerate threat

The regulatory regime that lets Intuitive move quickly also gives regulators continuing authority over an installed base of 11,710 machines.

The company devotes a standing section of its filings to field actions, recalls and corrections, and describes the definition as "expansive": it "includes repair, replacement, inspections, relabeling, and issuance of new or additional instructions for use or reinforcement of existing instructions for use and training when such actions are taken for specific reasons of safety or compliance"¹. Regulators "can require the expansion, reclassification, or change in scope and language of the field action."

The consequences it lists are what makes this a genuine risk rather than an administrative one: "damage to our reputation, delays by customers of purchase decisions, reduction or stoppage of the use of installed systems, and reduced revenue as well as increased expenses".

"Stoppage of the use of installed systems" is the phrase that matters. In a business where 84% of revenue is generated per procedure, an instruction that pauses use of a product line converts immediately into lost revenue across the whole base — not just lost sales to new customers.

Class II devices also carry special controls that can include post-market surveillance and patient registries², so the regulator has visibility into outcomes across the fleet.

Nothing currently disclosed suggests an active problem of that scale. The point is structural: Intuitive's revenue is more exposed to a field action than a conventional device maker's, because its revenue depends on the installed base being used today rather than on having been sold.